Trial intelligence / Profile preview

IV Glucocorticoids for Tear Film in TAO

NCT01579539Phase 3Completed

Sponsor
Medical University of Vienna
Start
Jun 2013
Primary completion
May 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection in thyroid associated ophthalmopathy (TAO), sponsored by Medical University of Vienna. Started Jun 2013; status: completed.

02

Drugs

methylprednisolone injection
03

Conditions

thyroid associated ophthalmopathy (TAO)

Beyond the preview

Go deeper on NCT01579539.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01579539.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call